Mirae Asset Global Investments Co., Ltd. Fate Therapeutics Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

  • $28 Billion
  • Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,428 shares of FATE stock, worth $5,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,428
Previous 3,942 12.33%
Holding current value
$5,490
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 21, 2025
BUY
$0.68 - $1.67 $330 - $811
486 Added 12.33%
4,428 $4,000
Q1 2025

Apr 24, 2025
BUY
$0.79 - $1.87 $116 - $274
147 Added 3.87%
3,942 $3,000
Q4 2024

Jan 27, 2025
BUY
$1.61 - $3.35 $6,109 - $12,713
3,795 New
3,795 $6,000
Q1 2024

May 01, 2024
BUY
$3.54 - $8.35 $208,275 - $491,272
58,835 New
58,835 $431,000
Q2 2023

Aug 10, 2023
SELL
$4.76 - $6.59 $96,827 - $134,053
-20,342 Reduced 22.11%
71,679 $341,000
Q1 2023

May 04, 2023
BUY
$4.24 - $11.12 $106,839 - $280,201
25,198 Added 37.71%
92,021 $524,000
Q4 2022

Feb 09, 2023
BUY
$9.86 - $23.83 $85,170 - $205,843
8,638 Added 14.85%
66,823 $674,000
Q3 2022

Nov 10, 2022
BUY
$21.04 - $36.06 $55,945 - $95,883
2,659 Added 4.79%
58,185 $1.3 Million
Q2 2022

Jul 26, 2022
BUY
$17.78 - $42.39 $529,577 - $1.26 Million
29,785 Added 115.71%
55,526 $1.38 Million
Q1 2022

May 10, 2022
BUY
$29.67 - $60.28 $130,874 - $265,895
4,411 Added 20.68%
25,741 $998,000
Q4 2021

Feb 08, 2022
BUY
$47.84 - $64.34 $176,433 - $237,285
3,688 Added 20.9%
21,330 $1.25 Million
Q3 2021

Nov 15, 2021
BUY
$59.27 - $95.73 $207,326 - $334,863
3,498 Added 24.73%
17,642 $1.05 Million
Q2 2021

Aug 11, 2021
BUY
$67.25 - $92.52 $135,239 - $186,057
2,011 Added 16.57%
14,144 $1.23 Million
Q1 2021

May 13, 2021
BUY
$72.16 - $117.4 $875,517 - $1.42 Million
12,133 New
12,133 $1 Million

Others Institutions Holding FATE

# of Institutions
145
Shares Held
97M
Call Options Held
56.7K
Put Options Held
5.4K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $120M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email